Long-term response to second-line afatinib treatment for advanced squamous cell carcinoma non-small cell lung cancer: a rare case report. [PDF]
J Int Med Res, 2020 The ErbB family is composed of four cell membrane receptors: ErbB-1 (epidermal growth factor receptor or human epidermal growth factor receptor [HER]1), ErbB-2 (HER2), ErbB-3 (HER3), and ErbB-4 (HER4).
Sun M +7 more
europepmc +2 more sources
Diagnostic Utility of TTF-1 and P40 Immunohistochemical Markers for Subtyping of Non-Small Cell Lung Carcinoma [PDF]
Journal of Medical Sciences and Health, 2023 Background : Lung cancer is the leading cause of cancer-related mortality over worldwide. Although the pathological diagnosis of lung carcinoma is limited as only small specimen available for diagnosis, the availability of targeted therapies has created ...
Anjana Arya +4 more
core +3 more sources
Cemiplimab for cutaneous squamous cell carcinoma, basal cell carcinoma, non-small cell lung cancer. [PDF]
Aust Prescr, 2022 europepmc +2 more sources
Exploiting metabolic vulnerabilities of Non small cell lung carcinoma [PDF]
Seminars in Cell & Developmental Biology, 2020 Lung cancer is the main cause of cancer death worldwide. Non-Small Cell Lung Carcinoma (NSCLC) is the most common subtype of lung cancer, and the prognosis of NSCLC patients in advanced stages is still very poor. Given the need for new therapies, the metabolism of NSCLC has been widely studied in the past two decades to identify vulnerabilities that ...
Majem, Blanca +2 more
openaire +6 more sources
Durvalumab for urothelial carcinoma, non-small cell lung cancer. [PDF]
Aust Prescr, 2019 europepmc +2 more sources
Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma
International Journal of Molecular Sciences, 2021 Lung cancer is one of the most common malignant neoplasms. As a result of the disease’s progression, patients may develop metastases to the central nervous system.
Agnieszka Rybarczyk-Kasiuchnicz +2 more
semanticscholar +1 more source
Epigenetics in non-small cell lung carcinomas [PDF]
Salud Pública de México, 2019 Objective. To perform a systematic review of the main epigenetic aberrations involved in non-small cell lung carcinomas’ (NSCLC) diagnosis, progression, and therapeutics. Materials and methods. We performed a systematic review of the scientific literature on lung cancer epigenetics, focusing on NSCLC. Results.
Federico Ávila-Moreno +3 more
openaire +3 more sources
Lung: Non-small cell carcinoma [PDF]
Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2011 Non-small cell carcinomas are divided into three main categories according to the predominant morphology of the tumour cells as determined by light microscopy. Although it is possible to distinguish different histological sub-groups in this way, or by using gene expression profiling, treatment is currently decided on the basis of tumour staging, age ...
J Heighway, DC Betticher
openaire +2 more sources
Artificial intelligence based prediction on lung cancer risk factors using deep learning [PDF]
International Journal of Informatics and Communication Technology
2023, Vol.12-2, 188-194, 2023 In this proposed work, we identified the significant research issues on lung cancer risk factors. Capturing and defining symptoms at an early stage is one of the most difficult phases for patients. Based on the history of patients records, we reviewed a number of current research studies on lung cancer and its various stages.
arxiv +1 more source
Sleeve segmentectomy for non–small cell lung carcinoma [PDF]
The Journal of Thoracic and Cardiovascular Surgery, 2004 Although sleeve segmentectomy for centrally located lung cancers was originally designed for patients unable to tolerate lobectomy, we have tried it in patients with noncompromised function as well. We evaluated the efficiency of this atypical type of bronchoplasty.Of 202 patients for whom we performed bronchoplasty for primary non-small cell lung ...
Morihito Okada +6 more
openaire +3 more sources